◆英語タイトル:The British United Provident Association Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013385
◆発行会社(調査会社):
GlobalData
◆発行日:2017年11月28日
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
The British United Provident Association Ltd (Bupa) is a leading global healthcare group. It offers health insurance and other funding products, chronic disease management services, home healthcare services, workplace health services and care services, comprising residential and nursing homes and retirement villages. It also manages hospitals, primary care centers and dental centers. It one of the leading international providers of nursing and residential care for elderly people. The group, along with its subsidiaries, operates in the UK, Australia, Spain, New Zealand, the USA, Saudi Arabia, Hong Kong, India, Thailand, China and Latin America. It offers its services to around 32 million customers in more than 190 countries worldwide. Bupa is headquartered in London, the UK.
Bupa reported gross written premiums of GBP7,139.3 million during the fiscal year 2015 (FY2015), representing an increase of 0.3% over FY2014. Its net insurance premiums earned were GBP7,010.4 million in FY2015, a decrease of 0.6% over FY2014.
The British United Provident Association Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
The British United Provident Association Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
The British United Provident Association Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
The British United Provident Association Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
The British United Provident Association Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
The British United Provident Association Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
The British United Provident Association Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Bupa To Acquire Aged Care Operations Of Innovative Care 10
Acquisition 11
Rite Aid Acquires Health Dialog Services From British United Provident Association 11
Bupa Acquires Barbican Dental Care 12
Bupa Completes Acquisition Of Altai Investments From Fortis Healthcare International For US$355 Million 13
Bupa Acquires Richmond Care Villages 15
Bupa Completes Acquisition Of Lux Med From Mid Europa Partners For US$529 Million 16
Bupa Australia Health Receives Supreme Court of Victoria’s Approval To Acquire Dental Corporation 18
The British United Provident Association Ltd – Key Competitors 20
The British United Provident Association Ltd – Key Employees 21
The British United Provident Association Ltd – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Joint Venture 24
Recent Developments 26
Financial Announcements 26
Aug 04, 2016: Bupa Half Year 2016 – modest growth in challenging market conditions 26
Corporate Communications 27
Jul 25, 2016: Bupa appoints Evelyn Bourke as CEO, Joy Linton appointed as CFO 27
Mar 29, 2016: Bupa appoints Joy Linton as Acting Chief Financial Officer 28
Mar 24, 2016: Bupa announces Stuart Fletcher to step down; Evelyn Bourke to be appointed Acting CEO from 4 April 29
Feb 09, 2016: Bupa Chief Legal Officer announces plan to retire 30
Jan 12, 2016: Bupa appoints Simon Blair and Janet Voute as Board Directors 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32
List of Tables
The British United Provident Association Ltd, Pharmaceuticals & Healthcare, Key Facts, 2015 2
The British United Provident Association Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
The British United Provident Association Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
The British United Provident Association Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
The British United Provident Association Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
The British United Provident Association Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Bupa To Acquire Aged Care Operations Of Innovative Care 10
Rite Aid Acquires Health Dialog Services From British United Provident Association 11
Bupa Acquires Barbican Dental Care 12
Bupa Completes Acquisition Of Altai Investments From Fortis Healthcare International For US$355 Million 13
Bupa Acquires Richmond Care Villages 15
Bupa Completes Acquisition Of Lux Med From Mid Europa Partners For US$529 Million 16
Bupa Australia Health Receives Supreme Court of Victoria’s Approval To Acquire Dental Corporation 18
The British United Provident Association Ltd, Key Competitors 20
The British United Provident Association Ltd, Key Employees 21
The British United Provident Association Ltd, Other Locations 23
The British United Provident Association Ltd, Subsidiaries 23
The British United Provident Association Ltd, Joint Venture 24